Antibody-mediated rejection at a glance
DSA inflames graft microvessels. Prove it with the Banff triad, treat in order, and call the regimen a centre protocol, not RCT-proven.
- Pathogenesis DSA binds endothelium; complement inflames microvessels.
- Banff triad Injury + antibody interaction + DSA.
- Plasma exchange and IVIG IVIG after each exchange; centre protocol.
-
Stop 1 · Assessment
Initial assessment and differential diagnosis
Stabilise first; timing narrows the differential.
Urgent dialysis indications
Anuria, or high Cr with hyperkalaemia or overload (e.g. Cr 400): urgent dialysis alongside work-up.
Key history
Immunosuppression, adherence, CNI trough, infections, time since transplant, commercial transplant.
First hours to days
Early graft dysfunction
Hyperacute rejection, vascular thrombosis, ischaemia-reperfusion / ATN, primary non-function, surgical (obstruction, leak, collection).
Months later
Later graft dysfunction
ABMR, TCMR, mixed, BK nephropathy, CMV, CNI toxicity, recurrent/de novo GN.
Doppler before biopsy: obstruction, collection, leak, TRAS (1–7% of post-transplant HTN), thrombosis. Also CNI-related TMA.
Memory hook“Hours: clot or hyperacute. Months: rejection, BK or CNI.” Within 8 h: surgical emergency.
Exam trapCommercial transplant, donor unknown: do NOT say “donor-specific antibody”. Report antibody screen generally; biopsy when safe; work up BK, CMV, ABMR, TCMR.
-
Stop 2 · Investigations
Diagnostic work-up
Subscribers only
Unlock the other 6 stops
Every drawing, memory hook and exam trap, the pocket check, the spoken answer, the viva questions and every section of this topic.
- Banff criteria
- Banff categories and differential diagnosis
- Treatment of active ABMR
- Refractory and chronic active ABMR
- Desensitisation